Rafferty Asset Management
DGX icon

Rafferty Asset Management’s Quest Diagnostics DGX Stock Holding History

Rafferty Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67M Sell
8,498
-3,477
-29% -$676K 0.01% 647
2025
Q4 		$2.08M Sell
11,975
-441
-4% -$80.3K 0.01% 639
2025
Q3 		$2.37M Buy
12,416
+613
+5% +$109K 0.01% 612
2025
Q2 		$2.12M Buy
11,803
+1,524
+15% +$265K 0.01% 593
2025
Q1 		$1.74M Sell
10,279
-2,380
-19% -$391K 0.01% 613
2024
Q4 		$1.91M Buy
12,659
+1,368
+12% +$213K 0.01% 658
2024
Q3 		$1.75M Sell
11,291
-798
-7% -$119K 0.01% 674
2024
Q2 		$1.65M Buy
12,089
+636
+6% +$87.1K 0.01% 698
2024
Q1 		$1.52M Buy
11,453
+16
+0.1% +$2.08K 0.01% 754
2023
Q4 		$1.58M Sell
11,437
-286
-2% -$37.6K 0.01% 731
2023
Q3 		$1.43M Buy
11,723
+880
+8% +$117K 0.01% 707
2023
Q2 		$1.52M Buy
10,843
+911
+9% +$126K 0.01% 718
2023
Q1 		$1.41M Buy
9,932
+132
+1% +$18.9K 0.01% 710
2022
Q4 		$1.53M Buy
9,800
+3,568
+57% +$513K 0.01% 646
2022
Q3 		$765K Buy
6,232
+3,384
+119% +$446K 0.01% 755
2022
Q2 		$379K Sell
2,848
-789
-22% -$108K ﹤0.01% 844
2022
Q1 		$498K Sell
3,637
-487
-12% -$67.9K ﹤0.01% 1000
2021
Q4 		$713K Buy
4,124
+227
+6% +$34.5K ﹤0.01% 994
2021
Q3 		$566K Buy
3,897
+994
+34% +$145K ﹤0.01% 1019
2021
Q2 		$383K Buy
2,903
+145
+5% +$19K ﹤0.01% 1122
2021
Q1 		$354K Buy
2,758
+179
+7% +$22.1K ﹤0.01% 1043
2020
Q4 		$307K Sell
2,579
-238
-8% -$29K ﹤0.01% 802
2020
Q3 		$323K Sell
2,817
-9,508
-77% -$1.12M ﹤0.01% 792
2020
Q2 		$1.41M Buy
+12,325
New +$1.31M 0.02% 450
2020
Q1 		– Sell
-3,638
Closed -$389K – 652
2019
Q4 		$389K Buy
+3,638
New +$379K 0.01% 735
2014
Q3 		– Sell
-6,654
Closed -$391K – 372
2014
Q2 		$391K Buy
+6,654
New +$390K 0.08% 190

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Rafferty Asset Management's DGX Position: Q1 2026 in Review

Rafferty Asset Management reduced its Quest Diagnostics (DGX) stake by 29% in Q1 2026, selling an estimated $676K and leaving 8,498 shares worth $1.67M. The position accounts for 0.01% of the portfolio, ranked #647.

Rafferty Asset Management first reported a position in DGX in Q2 2014 and has held it in 26 quarters since. The position peaked at $2.37M in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Rafferty Asset Management held 8,498 shares of Quest Diagnostics worth $1.67M as of Q1 2026.
  • Rafferty Asset Management sold 3,477 Quest Diagnostics shares in Q1 2026, an estimated $676K.
  • Quest Diagnostics made up 0.01% of Rafferty Asset Management's portfolio in Q1 2026, its #647 holding.
  • Rafferty Asset Management first reported a position in Quest Diagnostics in Q2 2014 and has held it in 26 quarters since.
  • Rafferty Asset Management's Quest Diagnostics position peaked at $2.37M in Q3 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.